|

CD19 or CD19-BCMA CAR-T Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Nanjing Bioheng Biotech Co., Ltd.1

Indications

  • ANCA Associated Vasculitis1
  • SLE (Systemic Lupus)1
  • Systemic Sclerosis1
  • Sjogren's Syndrome1
  • Idiopathic Inflammatory Myopathies1

Other1 trial

Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.